{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T15:46:41Z","timestamp":1769269601962,"version":"3.49.0"},"reference-count":31,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Monbl Augenheilkd"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ocular mucosal pemphigoid is a rare, chronically progressive autoimmune disease of the ocular surface. It belongs to a group of diseases whose common clinical correlate is the disruption of cohesion at the basement membrane. Recurrent inflammation with progressive fibrosis of the conjunctiva and damage to limbal stem cells are characteristic. If the course remains uncontrolled, severe morphological and functional damage can occur, up to blindness. Therefore, the critical perception of initially subtle findings and early diagnostic are of great importance. The aim of immune modulative therapy is to control the underlying inflammation and prevent the progression of fibrosis, in order to avoid serious complications.<\/jats:p>","DOI":"10.1055\/a-2566-3860","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T22:30:31Z","timestamp":1750113031000},"page":"653-659","source":"Crossref","is-referenced-by-count":2,"title":["Ocular Mucosal Pemphigoid: Diagnosis, Clinic and Therapy"],"prefix":"10.1055","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5569-1473","authenticated-orcid":false,"given":"Uwe","family":"Pleyer","sequence":"additional","affiliation":[{"name":"Universit\u00e4ts-Augenklinik, Charit\u00e9 Campus Virchow-Klinik, Berlin, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/j.jid.2016.07.013","article-title":"Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in Germany","volume":"136","author":"F H\u00fcbner","year":"2016","journal-title":"J Investig Dermatol Symp Proc"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/jdv.17107","article-title":"Incidence of pemphigoid diseases in Northern Germany in 2016 \u2013 first data from the Schleswig\u2010Holstein Registry of Autoimmune Bullous Diseases","volume":"35","author":"N Beek","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/ICO.0000000000003547","article-title":"Ocular Cicatricial Pemphigoid in Young Patients","volume":"43","author":"J Jinagal","year":"2024","journal-title":"Cornea"},{"key":"ref4","first-page":"370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment and prognostic indicators","volume":"138","author":"L S Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10792-024-02939-8","article-title":"Study Working Group of Rheumatological Ocular Diseases, Argentinian Society of Rheumatology. Ocular cicatricial pemphigoid: is there an association with autoimmune diseases?","volume":"44","author":"A Ringer","year":"2024","journal-title":"Int Ophthalmol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/ddg.14905","article-title":"S2\u2009k Guideline for the diagnosis and treatment of mucous membrane pemphigoid","volume":"20","author":"S C Hofmann","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/bjo.80.4.292","article-title":"Progression of disease in ocular cicatricial pemphigoid","volume":"80","author":"M J Elder","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0161-6420(81)35069-6","article-title":"Ocular Cicatricial Pemphigoid","volume":"88","author":"B J Mondino","year":"1981","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.ophtha.2022.06.001","article-title":"Utility of direct immunofluorescence using buccal mucosal biopsies in those with suspected isolated ocular mucous membrane pemphigoid","volume":"129","author":"S N Lopez","year":"2022","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/iovs.64.15.17","article-title":"Tissue Remodeling in Ocular Mucous Membrane Pemphigoid","volume":"64","author":"A Di Zazzo","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jtos.2022.02.004","article-title":"Drug induced cicatrizing conjunctivitis: A case series with review of etiopathogenesis, diagnosis and management","volume":"24","author":"S Singh","year":"2022","journal-title":"Ocul Surf"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1055\/s-0032-1328748","article-title":"Das okul\u00e4re vernarbende Pemphigoid \u2013 aktuelle Aspekte zu Klinik und Therapie einer problematischen Erkrankung","volume":"230","author":"A R\u00fcbsam","year":"2013","journal-title":"Klin Monbl Augenheilkd"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s00347-023-01856-y","article-title":"[Diagnostics of ocular mucous membrane pemphigoid]","volume":"120","author":"V Haralanova","year":"2023","journal-title":"Ophthalmologie"},{"key":"ref14","first-page":"527","article-title":"Cicatricial pemphigoid","volume":"84","author":"C S Foster","year":"1986","journal-title":"Trans Am Ophthalmol Soc"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1080\/09273948.2024.2376746","article-title":"A. Clinical Characteristics of Ocular Mucous Membrane Pemphigoid: A Systematic Review and Meta-Analysis","volume":"32","author":"N Bocanegra-Oyola","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ophtha.2020.07.052","article-title":"Autoantibody Detection for Diagnosis in Direct Immunofluorescence-Negative Mucous Membrane Pemphigoid: Ocular and Other Sites Compared","volume":"128","author":"J Dart","year":"2021","journal-title":"Ophthalmology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1080\/09273948.2024.2397715","article-title":"The Role of Serology in the Diagnosis of Ocular Predominant Mucous Membrane Pemphigoid and the Search for an Ocular-Specific Autoantigen","volume":"32","author":"D Sodha","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3390\/biom12101461","article-title":"Anti-laminin 332-type mucous membrane pemphigoid","volume":"12","author":"L Shi","year":"2022","journal-title":"Biomolecules"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1080\/09273948.2021.1939390","article-title":"A Review of Ocular Graft-versus-Host Disease: Pathophysiology, Clinical Presentation and Management","volume":"29","author":"J T Carreno-Galeano","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00347-021-01351-2","article-title":"[Ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis]","volume":"118","author":"A Chronopoulos","year":"2021","journal-title":"Ophthalmologe"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1055\/a-1720-1819","article-title":"Zur Versorgungssituation und konservativen Therapie des okul\u00e4ren vernarbenden Schleimhautpemphigoids in Deutschland","volume":"240","author":"R Ya\u00efci","year":"2023","journal-title":"Klin Monbl Augenheilkd"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1055\/a-1115-4756","article-title":"[If Artificial Tears Aren\u02bct Enough. The Importance of Inflammatory Processes in Dry Eye Disease. Practical Aspects of an Anti-Inflammatory Therapy of Dry Eye Disease]","volume":"237","author":"U Pleyer","year":"2020","journal-title":"Klin Monbl Augenheilkd"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1080\/09273948.2024.2413892","article-title":"Treatment of Ocular Surface Disease in Ocular Cicatricial Pemphigoid","volume":"32","author":"K S Abbott","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.3390\/jcm13133935","article-title":"Customized Scleral Lenses: An Alternative Tool for Severe Dry Eye Disease-A Case Series","volume":"13","author":"S Nunziata","year":"2024","journal-title":"J Clin Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.survophthal.2015.12.007","article-title":"Update on ocular cicatricial pemphigoid and emerging treatments","volume":"61","author":"M M Queisi","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1517\/14712598.2015.1046833","article-title":"Rituximab preserves vision in ocular mucous membrane pemphigoid","volume":"15","author":"A R\u00fcbsam","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.3390\/biomedicines10112844","article-title":"Bullous Pemphygoid and Novel Therapeutic Approaches","volume":"10","author":"G M D\u02bcAgostino","year":"2022","journal-title":"Biomedicines"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1016\/j.jcjo.2023.03.009","article-title":"Long-term outcomes of fornix reconstruction and cicatricial entropion repair in ocular mucous membrane pemphigoid and drug-related secondary pemphigoid","volume":"59","author":"H M Khan","year":"2024","journal-title":"Can J Ophthalmol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajo.2022.06.022","article-title":"Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II","volume":"243","author":"C Saini","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jtos.2022.03.005","article-title":"The evolution of the modified osteo-odonto-keratoprosthesis, its reliability, and long-term visual rehabilitation prognosis: An analytical review","volume":"24","author":"G Ortiz-Morales","year":"2022","journal-title":"Ocul Surf"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ophtha.2024.02.028","article-title":"Ocular Mucous Membrane Pemphigoid: The Effect of Risk Factors at Presentation on Treatment Outcomes","volume":"131","author":"R E Ruiz-Lozano","year":"2024","journal-title":"Ophthalmology"}],"container-title":["Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2566-3860.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T22:30:38Z","timestamp":1750113038000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2566-3860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":31,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2025,6,16]]},"published-print":{"date-parts":[[2025,6]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2566-3860","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0023-2165","1439-3999"],"issn-type":[{"value":"0023-2165","type":"print"},{"value":"1439-3999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}